Industry News
Targeting cystic fibrosis inflammation
An inflammation drug candidate has been chosen as a lead and will be advanced into development after showing high levels of activity in animal models of inflammatory respiratory disease.
[ + ]Salt-tolerant wheat made possible
The Molecular Plant Breeding CRC's Dr Yusuf Genc has found that different varieties of wheat have different ways of dealing with salinity. The research has implications for cereal breeders, who have long sought to breed varieties that are resistant to salinity.
[ + ]BIO profile: Apollo prepares for lift-off
Two major pre-clinical breakthroughs have set Apollo Life Sciences on the road to commercialising the company's large molecule delivery systems, with orally delivered insulin and TNF blockers just two of its targets. [ + ]
Changing of the guard at Merck
Phil Kearney has succeeded Graham Macdonald as the key scout for innovative research for Merck Sharpe & Dohme in the Asia Pacific. [ + ]
BIO 2007: Oz biotech looks set for a boomer
Last year wasn't the best on record for the Australian biotechnology industry but this year and the next look much more promising. Share prices are up, investors are showing more interest and there are a lot of good stories to tell and sell. [ + ]
ANSTO companies receive business boost
Two new companies ANSTO established early this year have each had a boost of $80,000 following the award of competitive-based COMET grants from the federal government, which supports early growth in spin-off companies to commercialise their innovations.
[ + ]Is gender important in skin cancer?
Differences in anti-oxidant levels between males and females may be why men are more likely to develop skin cancer, American researchers report. [ + ]
In search of the universal O
Danish researchers develop method to convert A, B and AB blood types into the universal O group. [ + ]
The proteins at the heart of telomerase
Australian researchers have identified the components of telomerase, the enzyme associated with uncontrolled cell growth, and it turns out to be very simple indeed. [ + ]
Checklist for maximising return on R&D
Successful ‘proof of concept’ implementation is the key to maximising return on R&D investment in universities, according to Science Industry Australia (SIA).
[ + ]Presidential DNA sheds light on ancestry
Research into the ancestry of US President, Thomas Jefferson has thrown new light onto his ancestry and the migration of a rare class of DNA.
[ + ]Rockeby receives approval for flu test
Rockeby Biomed has received the European approval, CE Mark, for its Human Antigen Detection Test for Influenza A.
[ + ]Ariadne arrives in Australia and New Zealand
Pathway Studio software and Ariadne products will be distributed by GeneWorks in Australia and New Zealand.
[ + ]Australian scientists identify cancer cells
Australian scientists have identified the leukaemia cells responsible for causing relapse after treatment in common childhood cancer.
[ + ]D1, D2 and Huntington's disease
Loss of D1 dopamine neurons, not D2, responsible for Huntington's symptoms, Florey researcher says. [ + ]